Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.

Source:http://linkedlifedata.com/resource/pubmed/id/21171821

Download in:

View as

General Info

PMID
21171821